Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses - Wikidata - awgldk - TriplyDB

Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses

Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses

http://www.wikidata.org/entity/Q27472844

about

Prolonged activation of virus-specific CD8+T cells after acute B19 infection.Diminished frequency of hepatitis C virus specific interferon secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection Hepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor That Can Suppress HCV-Specific T-Cell Responses Viral Sequence Evolution in Acute Hepatitis C Virus Infection CD8 Epitope Escape and Reversion in Acute HCV Infection Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals Lack of Disease Specificity Limits the Usefulness of In Vitro Costimulation in HIV- and HCV-Infected Patients Hepatitis C Virus-Specific T-Cell Gamma Interferon and Proliferative Responses Are More Common in Perihepatic Lymph Nodes than in Peripheral Blood or Liver Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness Underlying Pathophysiology of HCV Infection in HIV-Positive Drug Users Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection.Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection.Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patients Transcriptomic assay of CD8+ T cells in treatment-naïve HIV, HCV-mono-infected and HIV/HCV-co-infected Chinese.Hepatitis C and human immunodeficiency virus infection.Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.Reduced type 1 and type 2 cytokines in antiviral memory T helper function among women coinfected with HIV and HCV.HCV immunology--death and the maiden T cell.Coinfection with HIV-1 and HCV--a one-two punch.High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.Update on hepatitis C virus-specific immunity HCV-HIV coinfection: simple messages from a complex disease.A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort.Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts.Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?CD4+ T cell responses in hepatitis C virus infection.Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees.Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses.Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs.Stronger hepatitis C virus-specific CD8+ T-cell responses in HIV coinfection.HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.Mitochondrial abnormalities in patients with HIV-HCV co-infection as compared to patients with HCV mono-infection.Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.

P2860

Q24811737-0144D225-762A-4560-8838-9FB8350202C4 Q27477581-2D69340E-0DAB-4BC9-BAC8-EA2F021FB0A0 Q27477797-21866564-0FC2-4FDE-9CF0-BCE86E748A4C Q27480368-3D4BCC16-7316-4198-A7C4-491DDB374642 Q27484985-EA769A9F-DB2E-489C-8A2E-2D9B5F1E2441 Q27485189-2B66832F-F82E-44EE-B64D-3691F1070C36 Q27486399-67201EF7-F880-40CE-9CC7-A8F8096C59F9 Q27486527-9735F1AC-83DE-4BAB-A340-87D1FBB2BB2E Q27487339-79D59727-93D1-4867-BCFA-E5278062C830 Q27487966-2D675FFB-AA63-4D9F-BEB9-140BB22132E6 Q27489073-F8F4667B-A4C4-4D8E-8D21-A2DBCF8130AA Q33211869-BDA02982-E3AC-4AEF-8E1B-B0667D691228 Q33378514-89AD6B97-B107-46B7-AED6-11960EC17964 Q33730915-5C8D9976-F1E9-4373-928F-3362216C89A2 Q33767267-0D58FCD2-1635-4F5A-8751-A1337D2D46B1 Q34058230-4D068CED-9C93-4092-85C4-5E06F36FAECF Q34428339-9062280D-D037-489E-8040-AF45C02EF4DF Q34984125-A531CD68-E50A-4CCE-8E6D-876271BAB601 Q35056266-A8F3B484-76D6-40E4-AADD-B22EA2F2A09A Q35079621-AF4CE3F0-BA05-4AEF-A853-550E799B3077 Q35091469-93F8B799-151A-4C43-8703-5D987318D191 Q35137038-E47A789F-0F4B-4E23-8433-4A972861C3C1 Q35597143-3E003968-EE04-4E0E-91BD-D3114BF46EF0 Q35679577-FAFDC1E9-AD4D-4E76-992C-A59DE3612FFA Q35839496-F7B3ECFB-4418-4C74-A651-663EA10C33C8 Q36026387-2DA2E038-0DCB-454E-80EA-0CED781832B8 Q36084923-C8606F67-9E95-4E37-8AF4-CA332328D5B8 Q36330949-B5D6E78B-F7F7-45D8-865B-D632884D3777 Q36424006-6CCFDFA0-D588-4BB9-8468-2FA196FE3A5B Q36479368-9C14612C-BFFE-4AB7-9A17-1C42671D551A Q36935527-1569767B-887E-4087-BDAE-E1B78E20A43B Q37502673-F3992753-5450-4FB9-A4AD-CC96795026AC Q38086432-DAF649FE-C632-4619-8938-19B535449E24 Q41040128-2D5695FA-2735-433A-93C0-BCE53663ABCC Q42997258-7F6C7EE5-6EFD-4B13-AB90-395D2AA3B6C7 Q42998454-DA6DF1DB-1920-42E3-8C2B-14BAE0636045 Q43035090-68404627-92FD-4369-AEEE-84D407A4F6E0 Q43038579-BBF29D8B-A23C-40F6-B17A-65CAF9704091

P2860

Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses

http://www.wikidata.org/entity/Q27472844

description

2002 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մարտին հրատարակված գիտական հոդված

@hy

article scientifique (publié 2002-03)

@fr

articolo scientifico (pubblicato il 2002-03)

@it

artigo científico (publicado na 2002-03)

@pt

artículu científicu espublizáu en 2002

@ast

im März 2002 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: March 2002)

@en

vedecký článok (publikovaný 2002-03)

@sk

vetenskaplig artikel (publicerad på 2002-03)

@sv

name

Human Immunodeficiency Virus T ...... against Two Persistent Viruses

@ast

Human Immunodeficiency Virus T ...... against Two Persistent Viruses

@en

Human Immunodeficiency Virus T ...... against Two Persistent Viruses

@nl

type

label

Human Immunodeficiency Virus T ...... against Two Persistent Viruses

@ast

Human Immunodeficiency Virus T ...... against Two Persistent Viruses

@en

Human Immunodeficiency Virus T ...... against Two Persistent Viruses

@nl

prefLabel

Human Immunodeficiency Virus T ...... against Two Persistent Viruses

@ast

Human Immunodeficiency Virus T ...... against Two Persistent Viruses

@en

Human Immunodeficiency Virus T ...... against Two Persistent Viruses

@nl

P1433

Q27472844-5DB0FA2B-C81C-4670-8372-BBA210E779FE

P1476

Q27472844-0E23D6A1-80C4-4429-9896-82E9096F4DBB

P2093

Q27472844-20253EC3-EDD7-4927-AD40-53E16625F6AC

Q27472844-371F6B2C-FF56-4BEC-85D6-1EC3DE921446

Q27472844-63295BB9-6334-4FCC-BBBC-9B82FB9E79C5

Q27472844-9660425F-98EF-42B6-84ED-A9FCB9A8B7B1

Q27472844-AAF9B7EB-E21F-4D1F-A191-DA0CE5F451F4

Q27472844-BD430549-087F-4736-B183-EE58DDE03E7F

Q27472844-C78A8DC6-CDEB-4F5B-A19B-E9B9F679907B

P2860

Q27472844-0B9627E8-4120-4474-B1C9-4BC7061278FB

Q27472844-0F226AA7-6A13-49F3-B1F7-0636D9772F6D

Q27472844-19C24CD8-5856-4F07-8201-9B49091937A6

Q27472844-1ABEBBC8-C813-40C8-84AD-F26172DDC773

Q27472844-1AC74B1E-D5E1-41AA-A2E8-7BEDF1C9090A

Q27472844-1B6B07C0-A9EB-4747-B39F-0A4D412B7D4E

Q27472844-21A12F0A-7149-4750-A527-9B8F66B4C877

Q27472844-247CE228-B711-4A27-84F4-C12E4CE6EF78

Q27472844-2884A003-AA83-4287-B93D-E6E7140F2E03

Q27472844-295CCB36-2277-4F16-B712-47CE317944F2

P304

Q27472844-11CB41BA-E802-432C-9819-B51B0E415E85

P31

Q27472844-99A93196-455F-4416-88F7-873D9F3400F2

P3181

Q27472844-70957878-3C71-4425-84BA-71CB7B2BC5EE

P356

Q27472844-4011E76F-C455-418F-BA2E-524190A5B3DC

P433

Q27472844-7A22FEE7-28B7-48B4-A3D1-C9FF8CF1E0CC

P478

Q27472844-DF61733D-EF60-48DA-9A78-4523D58D0523

P50

Q27472844-767C644B-35A2-4390-BFE5-4FBBC4D91831

Q27472844-7966A6B7-0EE6-4223-B9E1-336091226705

Q27472844-A90B1A07-3077-46D2-AA22-B251E6319CBA

Q27472844-F0F547EE-1F4B-4E33-9470-0E5403BC2BBC

P577

Q27472844-06BCC444-DA8A-4443-A484-B3712AB4D6A7

P698

Q27472844-6F11C2F8-104E-41B0-93C0-64BA4B7F95A9

P921

Q27472844-1CC4C669-E4BC-487B-A35E-FC198A45925D

P932

Q27472844-48A3998B-22BF-4178-B040-DF07DF8AE780

P3181

P356

JVI.76.6.2817-2826.2002

P1433

Journal of Virology

P1476

Human Immunodeficiency Virus T ...... against Two Persistent Viruses

@en

P2093

Cheryl L Day

http://www.w3.org/2001/XMLSchema#string

Georg M Lauer

http://www.w3.org/2001/XMLSchema#string

Gregory K Robbins

http://www.w3.org/2001/XMLSchema#string

Katherine McGowan

http://www.w3.org/2001/XMLSchema#string

Michaela Lucas

http://www.w3.org/2001/XMLSchema#string

Tam N Nguyen

http://www.w3.org/2001/XMLSchema#string

Theresa Flynn

http://www.w3.org/2001/XMLSchema#string

P2860

Viral immune evasion due to persistence of activated T cells without effector function

Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release

Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

Analysis of successful immune responses in persons infected with hepatitis C virus

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

P304

2817-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4420759

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.76.6.2817-2826.2002

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Bruce D. Walker

Eric S Rosenberg

Raymond T Chung

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11861849

http://www.w3.org/2001/XMLSchema#string

P921

P932

135971

http://www.w3.org/2001/XMLSchema#string